Form D — Retension Pharmaceuticals, Inc.
0002002988-25-000002 · filed 2025-05-06
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $20,000,000
- Total sold
- $12,288,567
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Retension Pharmaceuticals, Inc.
- CIK
- 2002988
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- C/O REDUX THERAPEUTICS, LLC
MCLEAN, VA 22101 - Phone
- (703) 624-2024
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Eric Keller · Executive OfficerMcLean, VA Find on LinkedIn ↗
-
Michael Berendt · DirectorMcLean, VA Find on LinkedIn ↗
-
Donald Olds · DirectorMcLean, VA Find on LinkedIn ↗
View original on SEC EDGAR.